Anti Cancer Capsules
Leading 100% Export Oriented Unit of generic anti cancer medicines, 2.5mg letroz letrozole tablet, 100mg ciclib palbociclib capsules and 250mg gefticip gefitinib tablets from Nagpur.
Generic Anti Cancer Medicines
Approx. Price: Rs 250 / BoxGet Latest Price Product Details:
Minimum Order Quantity | 100 Box |
Dose/Strength | 400 mg |
Packaging Size | 1*10 capsules |
Type of Medicine | Allopathic |
Packaging Type | Strips,Bottles |
Dosage Form | Capsules |
Product Type | Finished product |
We are engaged in offering product to our clients. Our range of this products is widely appreciated by our clients.
2.5mg Letroz Letrozole Tablet
Approx. Price: Rs 984.81 / PieceGet Latest Price Product Details:
Dose/Strength | 2.5 mg |
Usage/Application | Clinical |
Brand | Letroz |
Packaging Size | 5x5 Tablets |
Packaging Type | Box |
Treatment | Helps Treat Breast Cancer In Post-menopausal |
Letroz 2.5mg Tablet helps treat breast cancer in post-menopausal women. It may be used alone or with other treatments, such as surgery or radiation. It can also be used in patients with advanced breast cancer to stop the tumor from spreading to other parts of the body.
100mg Ciclib Palbociclib Capsules
Approx. Price: Rs 5,500 / PieceGet Latest Price Product Details:
Strength | 100 mg |
Prescription/Non Prescription | Prescription |
Treatment | Helps In Treating Hiv Infection. |
Packaging Type | Box |
Shelf Life | 24 Month |
Brand | Ciclib |
Ciclib 100 Capsule is used to treat patients with certain types of breast cancer (estrogen receptor-positive, human epidermal growth factor receptor 2-negative) which have spread to other organs. It is given together with hormonal anticancer therapies.
250mg Gefticip Gefitinib Tablets
Approx. Price: Rs 5,491.42 / BoxGet Latest Price Product Details:
Dose/Strength | 250 mg |
Packaging Size | 1*20 Tablets |
Brand | Cipla |
Usage/Application | Clinical |
Manufacturer | Cipla |
Shelf Life | 24 Month |
Packaging Type | Box |
Gefticip 250mg Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung.